Looking ahead, challenges remain : drug manufacturers are responding by shifting strategies (for example, launching drugs at even higher prices initially, knowing they cant raise them as easily later, or focusing on orphan drug designations)
Kwon said, for example, GLP-1s are highly effective in improving blood pressure, diabetes and cholesterol
Who should avoid this treatment
These conditions disrupt hormonal regulation, which makes it hard to experience weight loss and appetite suppression
The rise of GLP-1 adoption is accelerating consumer interest in drinks that offer satiety, balanced blood sugar, and nutrient density with digestive health as a core part of that value proposition, said Ravi Jhala, VP of commercialization at US private label manufacturer, Fedup Foods, which focuses on functional and fermented beverages